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Abstract Direct sequencing of the coding region of the 
cystathionine ß-synthase (CBS) gene in two homocystin­
uric patients revealed the presence of two novel missense 
mutations. The first mutation, a 1111G —> A transition, re­
sulted in the substitution of the evolutionary conserved 
valine-371 by a methionine residue (V371M) and created 
a new NiaiII restriction site. The second mutation, a G->A 
transition at base-pair 494, resulted in an amino acid 
change from cysteine to tyrosine (C165Y) and abolished a 
BsoFl restriction site. Both mutations were found in a 
compound heterozygous state with the previously de­
scribed 833T —> C transition.
Introduction
Homocystinuria caused by cystathionine ß-synthase (CBS) 
deficiency is an inborn error of methionine metabolism 
and is inherited as an autosomal recessive trait. The pre­
dominant clinical manifestations of the homozygous state 
are arteriosclerosis, thromboembolic complications, skele­
tal abnormalities, ectopia lentis and mental retardation 
(Boers 1986; Mudd et al. 1989). The large range in the 
severity of the clinical features and in the biochemical re­
sponse to therapy suggests genetic heterogeneity of the 
CBS gene. CBS, a pyridoxal-phosphate-requiring enzyme, 
catalyzes the synthesis of cystathionine from homocys­
teine and serine (Finkelstein and Martin 1984). To date,
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14 mutations have been reported in the coding region of 
the CBS gene (Kraus 1994), which has been mapped to 
21q22.3 (Miincke et al. 1988). In this report, we describe 
the identification of two new missense mutations in this 
coding region.
Materials and methods
Patient 1 was a 33-year-old man who suffered from ectopia lends, 
osteoporosis, scoliosis and mental retardation. He also showed typ­
ically marfanoid features, such as arachnodactyly and dolichoste- 
nomelia. Therapy consisted of the daily administration of 750 mg 
pyridoxine, which reduced his total homocysteine levels to 35 
(.imol/l (control levels 8-18 jamol/1). Patient 2 was a 44-year-old 
male patient with many of the clinical features of homocystinuria: 
ectopia Ientis, thrombosis, seizures, arachnodactyly and scoliosis. 
Family examination showed that a sister and a brother were also 
affected. All were pyridoxine-responsive.
For mutation detection, R N A  was extracted from cultured fi­
broblasts (Chomczynski and Sacchi 1987) and firsl-strand cDNA 
was synthesized by standard methods. The cDNA product was am­
plified by the polymerase chain reaction (PCR) using three sets of 
oligonucleotides (Table 1). The generated PCR fragments covered 
the entire coding region and were subsequently subjected to direct 
sequencing according to the manufacturer’s recommendations (Ap­
plied Biosystems, Forster City, CA, USA).
Table 1 Primers used for PCR amplification and sequence analy^ 
sis of the cystathionine ß-synthase cDNA
Primer Nucleotide sequence (5" —»3 0 Nucleotide
position“
1 F GTCAGCACCATCTGTCCGGTC nt -26- -6
1 R CTCGGAGCTCATCTTCTCTGGC nt 528- 507
2 F GATCGGGCTGGCCCTGGC nt 453-■ 471
2 R CCCGCCTCATCCACCACGG nt 1358—1340
3 F GACCAAGTTCCTGAGCGACAGGTG nt 1146- 1169
3 R TCCTACCTGGCCGACTTCTCTC nt 1720-■1699
“The nucleotide position of the cystatliionine-ß-synthase cDNA is 
numbered according to Kraus et al. (1993)
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Fig. I  Comparison of amino 
acid sequences of homologous 
proteins of different species. 
CysK-Ecoli Escherichia coli 
acetylserine lyase; circ, 
CBS Mucor circinelloicles cys­
tathionine ß-synthase. The 
amino acids are indicated by 
capital letters. A gap (—) has 
been introduced to maintain 
alignment
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Results and discussion
Direct sequence analysis of the entire coding region of the 
CBS gene in patient 1 showed a novel 1111G —> A transi­
tion and the previously described 833T —> C (Î278T; Hu 
et al. 1993) missense mutation (data not shown). The ob­
served G-to-A transition resulted in an amino acid ex­
change from valine to methionine at codon 371 of the ma­
ture protein (V371M) and introduced a new NIalll restric­
tion site. Both transitions were confirmed at the genomic 
DNA level by NIalll and BsrI restriction analysis, respec­
tively. The substituted valine-371 residue appears to be 
highly conserved in homologous proteins in both prokary­
otic and eukaryotic species (Fig. 1). Evolutionary conser­
vation may indicate the functional relevance of an amino 
acid in the structure and function of the mature protein. 
Thus, this mutation is thought to interfere with the nonnal 
functioning of the CBS protein.
Patient 2 was found to be a compound heterozygote for 
the 833T C missense mutation and a novel 494G —> A 
transition. This latter transition resulted in a substitution 
of cysteine-165 by tyrosine (C165Y) in the CBS protein 
and abolished a BsoFl restriction site. The putative amine 
acid is located in the catalytic domain of the protein (J. P. 
Kraus, personal communications). This G-to-A transition 
may disrupt a disulphide bond in this catalytic domain. 
The disruption of a disulphide bond could interfere with 
intermolecular interactions and consequently with the cat­
alytic activity of the protein. However, the present data 
provide no indications whether these two new missence 
mutations are compatible with pyridoxine responsiveness
in vivo, because the other mutation (833T —> C) is associ­
ated with responsiveness both in the homozygous and in 
the compound heterozygous states (Hu et al. 1993).
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